Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Cascadian Therapeutics Inc (CASC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2016	06-2016	03-2016	12-2015	09-2015
Cash Flows From Operating Activities
Net Income	-47,193	-36,420	-12,887	-32,581	-23,450
Depreciation Amortization	622	364	189	918	730
Accounts receivable	-40	20	-73	98	-3
Accounts payable and accrued liabilities	302	871	393	-250	-300
Other Working Capital	-5,788	902	254	273	-721
Other Operating Activity	24,061	15,577	2,352	2,765	2,174
Operating Cash Flow	$-28,036	$-18,686	$-9,772	$-28,777	$-21,570

Cash Flows From Investing Activities
Change In Deposits	-26,716	-1,376	-4,139	24,471	14,614
PPE Investments	-74	-59	-59	-771	-739
Investing Cash Flow	$-26,790	$-1,435	$-4,198	$23,700	$13,875

Cash Flows From Financing Activities
Common Stock Issued	29,865	29,833	N/A	20,703	20,642
Other Financing Activity	13,663	13,438	0	1,770	1,863
Financing Cash Flow	$43,528	$43,271	$N/A	$22,473	$22,505

Beginning Cash Position	27,850	27,850	27,850	10,454	10,454
End Cash Position	16,552	51,000	13,880	27,850	25,264
Net Cash Flow	$-11,298	$23,150	$-13,970	$17,396	$14,810

Free Cash Flow
Operating Cash Flow	-28,036	-18,686	-9,772	-28,777	-21,570
Capital Expenditure	-74	-59	-59	-771	-739
Free Cash Flow	-28,110	-18,745	-9,831	-29,548	-22,309